This trial is testing whether a combination of two different drugs may help patients with mucosal melanoma.
1 Primary · 6 Secondary · Reporting Duration: Up to 5 years
Active Control
Experimental Treatment
99 Total Participants · 3 Treatment Groups
Primary Treatment: Nivolumab · Has Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: